CLINICAL_TRIALS
trial_result
· 2024-05-23
Clinical Trial Update: A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes [Phase 1]
Summary
Phase 1 study results for LY900018 (nasal glucagon) in pediatric participants with Type 1 diabetes mellitus have been posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2024-05-23